Cyclosporine, combination immunosuppression, and posttransplant diabetes mellitus

Transplant Proc. 1987 Feb;19(1 Pt 2):1811-3.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Age Factors
  • Antilymphocyte Serum / adverse effects
  • Antilymphocyte Serum / therapeutic use
  • Azathioprine / adverse effects
  • Azathioprine / therapeutic use
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Cyclosporins / adverse effects*
  • Cyclosporins / therapeutic use
  • Diabetes Mellitus / chemically induced
  • Diabetes Mellitus / etiology*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunosuppression / adverse effects*
  • Kidney Transplantation* / adverse effects
  • Male
  • Middle Aged
  • Prednisone / adverse effects
  • Prednisone / therapeutic use
  • Random Allocation

Substances

  • Antilymphocyte Serum
  • Cyclosporins
  • Azathioprine
  • Prednisone